Cleavable Lipids - EP3336082

The patent EP3336082 was granted to Translate BIO on Apr 15, 2020. The application was originally filed on Jun 8, 2012 under application number EP18153312A. The patent is currently recorded with a legal status of "Revoked".

EP3336082

TRANSLATE BIO
Application Number
EP18153312A
Filing Date
Jun 8, 2012
Status
Revoked
Aug 26, 2022
Grant Date
Apr 15, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

DILGJan 15, 2021MAIWALDADMISSIBLE
GLAXOSMITHKLINEJan 15, 2021WESTADMISSIBLE

Patent Citations (35) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS19970835281-
DESCRIPTIONUS19980083294-
DESCRIPTIONWO2010US58457-
DESCRIPTIONUS4737323
DESCRIPTIONUS4897355
DESCRIPTIONUS4920016
DESCRIPTIONUS4946683
DESCRIPTIONUS5171678
DESCRIPTIONUS5194654
DESCRIPTIONUS5223263
DESCRIPTIONUS5334761
DESCRIPTIONUS5677124
DESCRIPTIONUS5744335
DESCRIPTIONUS5885613
DESCRIPTIONWO2005121348
DESCRIPTIONWO2010042877
DESCRIPTIONWO2010053572
OPPOSITIONUS5965434
OPPOSITIONUS7745651
OPPOSITIONWO2006053646
OPPOSITIONWO2009026328
OPPOSITIONWO2010019718
OPPOSITIONWO2010042877
OPPOSITIONWO2010053572
OPPOSITIONWO2010054401
OPPOSITIONWO2011012316
OPPOSITIONWO2011071860
OPPOSITIONWO2018089790
OPPOSITIONWO2020106946
OPPOSITIONWO9527721
OTHERWO2011071860
SEARCHUS5965434
SEARCHWO2009026328
SEARCHWO2010019718
SEARCHWO2010054401

Non-Patent Literature (NPL) Citations (49) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ANCHORDOQUY et al., J. Pharm. Sci., (20000000), vol. 89, pages 289 - 296-
DESCRIPTION- Ann. Rev. Biophys. Bioeng., (19810000), vol. 10, pages 421 - 450-
DESCRIPTION- BEHR et al., Proc. Nat.'l Acad. Sci., (19890000), vol. 86, page 6982-
DESCRIPTION- FECHTER, P. et al., J. Gen. Virology, (20050000), vol. 86, pages 1239 - 1249-
DESCRIPTION- FEIGNER et al., Proc. Nat'l Acad. Sci., (19870000), vol. 84, page 7413-
DESCRIPTION- GAO et al., Biochem. Biophys. Res. Comm., (19910000), vol. 179, page 280-
DESCRIPTION- HEIDENREICH, J Biol Chem, (19940000), vol. 269, pages 2131 - 8-
DESCRIPTION- HEYES, J. et al., J Controlled Release, (20050000), vol. 107, pages 276 - 287-
DESCRIPTION- KARIKO, K. et al., Molecular Therapy, (20080000), vol. 16, no. 11, pages 1833 - 1840-
DESCRIPTION- KLIBANOV et al., FEBS Letters, (19900000), vol. 268, no. 1, pages 235 - 237-
DESCRIPTION- KOLTOVER et al., Science, (19980000), vol. 281, pages 78 - 81-
DESCRIPTION- KOZAK, M., Nucleic Acids Res, (19870000), vol. 15, no. 20, pages 8125 - 48-
DESCRIPTION- KRIEG et al., Melton. Methods in Enzymology, (19870000), vol. 155, pages 397 - 415-
DESCRIPTION- LASIC et al., FEBS Lett., (19920000), vol. 312, pages 255 - 258-
DESCRIPTION- LIEBHABER, J. Mol. Biol., (19920000), vol. 226, pages 2 - 13-
DESCRIPTION- MONIA et al., J Biol Chem., (19930000), vol. 268, pages 14514 - 22-
DESCRIPTION- MORRISSEY, DV. et al., Nat. Biotechnol., (20050000), vol. 23, no. 8, pages 1003 - 1007-
DESCRIPTION- NG et al., Nature Genetics, (20100000), vol. 42, pages 1035 - 1036-
DESCRIPTION- N.J. CAPLEN, Gene Ther., (19950000), vol. 2, page 603-
DESCRIPTION- PONSA et al., Int. J. Pharm., (19930000), vol. 95, pages 51 - 56-
DESCRIPTION- "Reduction of Liposome Size and Preparation of Unilamellar Vesicles by Extrusion Techniques", HOPE, M J et al., Liposome Technology, (19930000), vol. 1, page 123-
DESCRIPTION- Remington's Pharmaceutical Sciences, Mack Publishing Co.-
DESCRIPTION- SEMPLE et al., nature Biotech, (20100000), vol. 28, pages 172 - 176-
DESCRIPTION- S. LI et al., Gene Ther., (19970000), vol. 4, page 891-
DESCRIPTION- WENDER et al., Adv. Drug Del. Rev., (20080000), vol. 60, pages 452 - 472-
DESCRIPTION- WOLF et al., BioTechniques, (19970000), vol. 23, page 139-
DESCRIPTION- YOKOE et al., Nature Biotechnology, (19960000), vol. 14, pages 1252 - 1256-
EXAMINATION- Chengjun Chen ET AL, "An overview of liposome lyophilization and its future potential", JOURNAL OF CONTROLLED RELEASE, NL, (20100301), vol. 142, no. 3, doi:10.1016/j.jconrel.2009.10.024, ISSN 0168-3659, pages 299 - 311, XP055226732
OPPOSITION- Anonymous, "Gefriertrocknung mit System: Grundlagen, optimierte Prozessführung und Anwendungen", ChRist, (20090701), pages 1 - 54, ChRist, (20201201), XP055755528-
OPPOSITION- Christ, "Operating manual freeze-dryer Alpha 1-4 LCS plus and Alpha 2-4 LSC plus", Christ, (20131216), pages 1 - 121, Christ, (20221031), XP055976383-
OPPOSITION- Cortesi R; Esposito E; Nastruzzi C, "Effect of DNA complexation and freeze-drying on the physicochemical characteristics of cationic liposomes", ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT., MARY ANN LIEBERT, INC., NEW YORK., US, US , (20000601), vol. 10, no. 3, ISSN 1087-2906, pages 205 - 215, XP009127308-
OPPOSITION- Daucik Karol, "Revised Release on the Pressure along the Melting and Sublimation Curves of Ordinary Water Substance Contents", International Association for the Properties of Water and Steam /IAPWS R14-08(2011)/, (20110901), pages 1 - 7, XP055979837-
OPPOSITION- van Winden Ewoud C, "Freeze-drying of liposomes: theory and practice.", Methods in Enzymology, Elsevier, Academic Press, NL, NL , (20030101), vol. 367, ISBN 978-0-12-805382-9, pages 99 - 110, XP009136646-
OPPOSITION- "VAPOR PRESSURE OF ICE", Rumble John R, Bruno Thomas J, Doa Maria J, CRC Handbook of Chemistry and Physics A Ready-Reference Book of Chemical and Physical Data, 101st Edition, CRC Press, (20200101), page 3pp, XP055979839-
OPPOSITION- Shayne Cox Gad Et Al, "RNA-based Therapies", Design and Pharmaceutical Applications of Prodrugs, JOHN WILEY & SONS, INC. , (20050101), pages 1259 - 1308, doi:10.1002/0471728780.ch27, ISBN 978-0-471-21384-0, XP055415554
OPPOSITION- MOLINA MARION D C ET AL, "The stability of lyophilized lipid/DNA complexes during prolonged storage", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, US , (20040901), vol. 93, no. 9, doi:10.1002/JPS.20138, ISSN 0022-3549, pages 2259 - 2273, XP002527009
OPPOSITION- Carralot J.-P.; Probst J.; Hoerr I.; Scheel B.; Teufel R.; Jung G.; Rammensee H.-G.; Pascolo S., "Polarization of immunity induced by direct injection of naked sequence-stabilized mRNA vaccines", CMLS CELLULAR AND MOLECULAR LIFE SCIENCES., BIRKHAUSER VERLAG, HEIDELBERG., DE, DE , (20040901), vol. 61, no. 18, doi:10.1007/s00018-004-4255-0, ISSN 1420-682X, pages 2418 - 2424, XP037066067
OPPOSITION- Chen, C. ; Han, D. ; Cai, C. ; Tang, X., "An overview of liposome lyophilization and its future potential", Journal of Controlled Release, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20100319), vol. 142, no. 3, doi:10.1016/j.jconrel.2009.10.024, ISSN 0168-3659, pages 299 - 311, XP026930148
OPPOSITION- Eberhardt, W. Doller, A. Akool, E.S. Pfeilschifter, J., "Modulation of mRNA stability as a novel therapeutic approach", Pharmacology & Therapeutics, ELSEVIER., GB, GB , (20070331), vol. 114, no. 1, doi:10.1016/j.pharmthera.2007.01.002, ISSN 0163-7258, pages 56 - 73, XP022011304
OPPOSITION- Giovanna Montana, Maria L. Bondì, Rita Carrotta, Pasquale Picone, Emanuela F. Craparo, Pier L. San Biagio, Gaetano Giammona, Marta Di Carlo, "Employment of cationic solid-lipid nanoparticles as RNA carriers.", Bioconjugate Chemistry, American Chemical Society, US, US , (20070301), vol. 18, no. 2, doi:10.1021/BC0601166, ISSN 1043-1802, pages 302 - 308, XP002683928
OPPOSITION- Xingfang Su, Jennifer Fricke, Daniel G. Kavanagh, Darrell J. Irvine, "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", Molecular Pharmaceutics, American Chemical Society, (20110606), vol. 8, no. 3, doi:10.1021/mp100390w, ISSN 15438384, pages 774 - 787, XP055127583
OPPOSITION- TANG X., PIKAL M.J., "Design of Freeze-Drying Processes for Pharmaceuticals: Practical Advice", Pharmaceutical Research, Springer US, New York, New York, (20040201), vol. 21, no. 2, doi:10.1023/B:PHAM.0000016234.73023.75, ISSN 0724-8741, pages 191 - 200, XP002370775
OPPOSITION- D. B. Fenske, A. Chonn, P. R. Cullis, "Liposomal Nanomedicines: An Emerging Field", Toxicologic Pathology, (20080101), vol. 36, no. 1, doi:10.1177/0192623307310960, ISSN 01926233, pages 21 - 29, XP055179556
OPPOSITION- YADAVA PREETI ET AL, "Effect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexes.", AAPS PHARMSCITECH, Springer New York LLC, US, US , (20080601), vol. 9, no. 2, doi:10.1208/S12249-007-9000-1, ISSN 1530-9932, pages 335 - 341, XP002511465
OPPOSITION- Aso Yukio, Yoshioka Sumie, "Effect of Freezing Rate on Physical Stability of Lyophilized Cationic Liposomes", Chemical and Pharmaceutical Bulletin, Pharmaceutical Society of Japan, JP, JP , (20050101), vol. 53, no. 3, doi:10.1248/cpb.53.301, ISSN 0009-2363, pages 301 - 304, XP055976379
OPPOSITION- JONES K.L., DRANE D. & GOWANS E.J., "Long-term storage of DNA-free RNA for use in vaccine studies", Biotechniques, Informa Healthcare, US, US , (20071101), vol. 43, no. 5, doi:10.2144/000112593, ISSN 0736-6205, pages 675 - 681, XP002581476
SEARCH- EBERHARDT ET AL, "Modulation of mRNA stability as a novel therapeutic approach", PHARMACOLOGY AND THERAPEUTICS, ELSEVIER, GB, (20070331), vol. 114, no. 1, doi:10.1016/J.PHARMTHERA.2007.01.002, ISSN 0163-7258, pages 56 - 73, XP022011304 [Y] 2 * the whole document *
SEARCH- GIOVANNA MONTANA ET AL, "Employment of cationic solid-lipid nanoparticles as RNA carriers", vol. 18, no. 2, doi:10.1021/BC0601166, ISSN 1043-1802, (20070301), pages 302 - 308, BIOCONJUGATE CHEMISTRY,, URL: http://pubs.acs.org/doi/abs/10.1021/bc0601166, (20070125), XP002683928 [I] 1-19 * abstract * * page 302, right column, line 13 * [Y] 1,8-10,15
SEARCH- XINGFANG SU ET AL, "In Vitro and in Vivo mRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles", MOLECULAR PHARMACEUTICS, (20110606), vol. 8, no. 3, doi:10.1021/mp100390w, ISSN 1543-8384, pages 774 - 787, XP055127583 [I] 1-19 * abstract * * page 775, "synthesis"; page 776 "RNA release" and "transfection"; page 778, left column * [Y] 8-10

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents